Evoke Pharma Current Ratio 2012-2019 | EVOK

Evoke Pharma current ratio from 2012 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Evoke Pharma Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-03-31 $0.00B $0.00B 3.31
2018-12-31 $0.01B $0.00B 3.46
2018-09-30 $0.01B $0.00B 4.35
2018-06-30 $0.01B $0.00B 5.23
2018-03-31 $0.01B $0.00B 4.67
2017-12-31 $0.01B $0.00B 3.82
2017-09-30 $0.01B $0.00B 4.06
2017-06-30 $0.01B $0.00B 7.00
2017-03-31 $0.02B $0.00B 13.05
2016-12-31 $0.01B $0.00B 6.58
2016-09-30 $0.01B $0.00B 10.69
2016-06-30 $0.01B $0.01B 0.75
2016-03-31 $0.01B $0.00B 2.82
2015-12-31 $0.01B $0.00B 5.19
2015-09-30 $0.01B $0.00B 5.82
2015-06-30 $0.01B $0.00B 3.32
2015-03-31 $0.01B $0.00B 5.03
2014-12-31 $0.02B $0.00B 8.24
2014-09-30 $0.01B $0.00B 7.90
2014-06-30 $0.02B $0.00B 9.22
2014-03-31 $0.02B $0.00B 7.48
2013-12-31 $0.02B $0.00B 10.69
2013-09-30 $0.02B $0.00B 9.00
2013-06-30 $0.00B $0.00B 0.61
2013-03-31 $0.00B 0.00
2012-12-31 $0.00B 0.00
2012-09-30 $0.00B 0.00
2012-06-30 $0.00B 0.00
2011-12-31 $0.00B $0.00B 2.73
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.022B $0.000B
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $52.895B 9.65
Mylan (MYL) United Kingdom $9.848B 4.34
Teva Pharmaceutical Industries (TEVA) Israel $8.135B 3.20
Bausch Health Cos (BHC) Canada $7.882B 5.26
Dr Reddy's Laboratories (RDY) India $5.820B 19.58
ASPEN PHARMACR (APNHY) South Africa $2.077B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.439B 14.07
Amphastar Pharmaceuticals (AMPH) United States $1.068B 52.60
Homology Medicines (FIXX) United States $0.789B 0.00
Voyager Therapeutics (VYGR) United States $0.782B 0.00
CymaBay Therapeutics (CBAY) United States $0.407B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.387B 0.53
Akorn (AKRX) United States $0.341B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.334B 0.00
Assembly Biosciences (ASMB) United States $0.324B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.276B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.171B 0.00
Sol-Gel Technologies (SLGL) Israel $0.157B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.087B 0.00
Teligent (TLGT) United States $0.038B 0.00
China Pharma Holdings (CPHI) China $0.011B 0.00